Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Institute of Human Genetics, |
RCV001262309 | SCV001440125 | likely pathogenic | Retinitis pigmentosa 39 | 2019-01-01 | criteria provided, single submitter | clinical testing | This variant was identified as compound heterozygous. |
Labcorp Genetics |
RCV002537633 | SCV003352451 | pathogenic | not provided | 2022-04-24 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Gln3255*) in the USH2A gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in USH2A are known to be pathogenic (PMID: 10729113, 10909849, 20507924, 25649381). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with USH2A-related conditions. ClinVar contains an entry for this variant (Variation ID: 982688). For these reasons, this variant has been classified as Pathogenic. |
Genome- |
RCV001262309 | SCV004182667 | likely pathogenic | Retinitis pigmentosa 39 | 2023-11-04 | criteria provided, single submitter | clinical testing |